McKesson Corp (NYSE:MCK)
$ 613 5.49 (0.9%) Market Cap: 77.81 Bil Enterprise Value: 82.52 Bil PE Ratio: 31.75 PB Ratio: 0 GF Score: 82/100

Mckesson Corp at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2022 / 12:00PM GMT
Release Date Price: $347.89 (-4.35%)
Erin Elizabeth Wilson Wright
Morgan Stanley, Research Division - Equity Analyst

Hi. Good morning, everyone. Thanks for joining us today on the second day of the Morgan Stanley Healthcare Conference. My name is Erin Wright. I'm Morgan Stanley's health care services and distribution analyst. I am pleased to have McKesson's CFO, Britt Vitalone, here with us today. McKesson is a leading drug distributor and IT services provider to health care providers and pharmaceutical companies.

Before we get started, I do have to do some disclosures here. For important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com. If you have any questions, please reach out to your Morgan Stanley sales representative. And with that, thanks again, Britt, for joining us today. And I'll turn it over to you for some introductory remarks.

Britt J. Vitalone
McKesson Corporation - Executive VP & CFO

Well, thank you, and good morning, everyone. We're really pleased to be here, and thank you for hosting us. McKesson as a global health care

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot